Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.
[PURPOSE] We analyzed all patients who underwent local transanal surgery at our institution to determine oncological outcomes and perioperative risk.
APA
Gascon MA, Aguilella V, et al. (2022). Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.. Langenbeck's archives of surgery, 407(6), 2431-2439. https://doi.org/10.1007/s00423-022-02593-7
MLA
Gascon MA, et al.. "Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.." Langenbeck's archives of surgery, vol. 407, no. 6, 2022, pp. 2431-2439.
PMID
35732844
Abstract
[PURPOSE] We analyzed all patients who underwent local transanal surgery at our institution to determine oncological outcomes and perioperative risk.
[METHODS] In 1997, we developed a prospective protocol for rectal tumors: transanal local full-thickness excision was considered curative in patients with benign adenoma and early cancers. In this analysis, 404 patients were included. To analyze survival, only those patients exposed to the risk of dying for at least 5 years were considered for the study.
[RESULTS] The final pathological analysis revealed that 262 (64.8%) patients had benign lesions, whereas 142 had malignant lesions. Postoperative complications were recorded in 12.6%. At the median time of 21 months, 14% of the adenomas and 12% of cancers had recurred, half of which were surgically resected. The overall 5-year survival rate was 94%.
[CONCLUSION] With similar outcomes and significantly lower morbidity, we found local surgery to be an adequate alternative to radical surgery in selected cases of early rectal cancer.
[METHODS] In 1997, we developed a prospective protocol for rectal tumors: transanal local full-thickness excision was considered curative in patients with benign adenoma and early cancers. In this analysis, 404 patients were included. To analyze survival, only those patients exposed to the risk of dying for at least 5 years were considered for the study.
[RESULTS] The final pathological analysis revealed that 262 (64.8%) patients had benign lesions, whereas 142 had malignant lesions. Postoperative complications were recorded in 12.6%. At the median time of 21 months, 14% of the adenomas and 12% of cancers had recurred, half of which were surgically resected. The overall 5-year survival rate was 94%.
[CONCLUSION] With similar outcomes and significantly lower morbidity, we found local surgery to be an adequate alternative to radical surgery in selected cases of early rectal cancer.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | adenoma
|
C0001430
Adenoma
|
scispacy | 1 | |
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | tumors
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | benign adenoma
|
C0001430
Adenoma
|
scispacy | 1 | |
| 질환 | cancers
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | malignant lesions
|
C5205543
Malignant Lesion
|
scispacy | 1 | |
| 질환 | adenomas
|
C0001430
Adenoma
|
scispacy | 1 | |
| 질환 | cT1-2 rectal cancer
|
scispacy | 1 | ||
| 질환 | rectal tumors
|
scispacy | 1 | ||
| 질환 | benign lesions
|
scispacy | 1 | ||
| 질환 | rectal cancer
|
scispacy | 1 | ||
| 기타 | full-thickness
|
scispacy | 1 |
MeSH Terms
Adenoma; Digestive System Surgical Procedures; Humans; Microsurgery; Neoplasm Recurrence, Local; Prospective Studies; Rectal Neoplasms; Retrospective Studies; Treatment Outcome